ロード中...
Comparison of the Effectiveness and Safety of Vildagliptin Add-On to Metformin Versus Other Oral Dual Antidiabetes Agents in Patients with Type 2 Diabetes: The China Prospective Diabetes Study
INTRODUCTION: The efficacy and safety of vildagliptin alone or with metformin is well established by randomized trials, but it is unknown whether it can be extrapolated to the real-world setting in Chinese patients with type 2 diabetes mellitus (T2DM). This study aimed to assess the effectiveness an...
保存先:
| 出版年: | Diabetes Ther |
|---|---|
| 主要な著者: | , , , , , , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Springer Healthcare
2019
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6612354/ https://ncbi.nlm.nih.gov/pubmed/31222594 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s13300-019-0645-z |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|